State Street Corporation 13D and 13G filings for Altimmune, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-17 11:16 am Sale | 2024-09-30 | 13G | Altimmune, Inc. ALT | STATE STREET CORP STT | 3,413,827 4.800% | -495,459 (-12.67%) | Filing |
| 2024-07-10 06:35 am Sale | 2024-06-30 | 13G | Altimmune, Inc. ALT | STATE STREET CORP STT | 3,909,286 5.510% | -4,739,984 (-54.80%) | Filing |
| 2024-04-10 09:40 am Purchase | 2024-03-31 | 13G | Altimmune, Inc. ALT | STATE STREET CORP STT | 8,649,270 12.200% | 7,634,724 (+752.53%) | Filing |
| 2024-01-23 10:50 am Purchase | 2023-12-31 | 13G | Altimmune, Inc. ALT | STATE STREET CORP STT | 1,014,546 1.890% | 210,473 (+26.18%) | Filing |
| 2023-07-10 2:31 pm Sale | 2023-06-30 | 13G | Altimmune, Inc. ALT | STATE STREET CORP STT | 804,073 1.630% | -5,110,515 (-86.41%) | Filing |
| 2023-01-10 08:00 am Purchase | 2022-12-31 | 13G | Altimmune, Inc. ALT | STATE STREET CORP STT | 5,914,588 12.030% | 5,223,447 (+755.77%) | Filing |
| 2022-04-11 1:42 pm Sale | 2022-03-31 | 13G | Altimmune, Inc. ALT | STATE STREET CORP STT | 691,141 1.600% | -3,730,400 (-84.37%) | Filing |
| 2022-02-11 07:38 am Purchase | 2021-12-31 | 13G | Altimmune, Inc. ALT | STATE STREET CORP STT | 4,421,541 11.130% | 430,400 (+10.78%) | Filing |
| 2021-09-10 2:19 pm Purchase | 2021-08-31 | 13G | Altimmune, Inc. ALT | STATE STREET CORP STT | 3,991,141 10.050% | 3,991,141 (New Position) | Filing |